Generalizability of studies on mental health treatment and outcomes, 1981 to 1996

被引:31
作者
Braslow, JT
Duan, NH
Starks, SL
Polo, A
Bromley, E
Wells, KB
机构
[1] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA
[2] Dept Vet Affairs, Mental Illness Res Educ & Clin Ctr, Los Angeles, CA USA
[3] Univ Calif Los Angeles, Dept Biostat, Los Angeles, CA 90024 USA
[4] RAND Corp, Santa Monica, CA USA
[5] Univ Calif Los Angeles, Dept Hlth Serv, Los Angeles, CA 90024 USA
[6] Univ Calif Los Angeles, Dept Clin Psychol, Los Angeles, CA 90024 USA
[7] Univ Calif Los Angeles, Robert Wood Johnson Clin Scholars Program, Los Angeles, CA 90024 USA
关键词
D O I
10.1176/appi.ps.56.10.1261
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: This study operationalized and measured the external validity, or generalizability, of studies on mental health treatment and outcomes published in four journals between 1981 and 1996. Method: MEDLINE was searched for articles on mental health treatment and outcomes that were published in four leading psychiatry and psychology journals between 1981 and 1996. A 156-item instrument was used to assess generalizability of study findings. Results: Of more than 9,000 citations, 414 eligible studies were identified. Inclusion of community sites and patients from racial or ethnic minority groups were documented in only 12 and 25 percent of studies, respectively. Random or systematic sampling methods were rare (3 percent), and 75 percent of studies did not explicitly address sample representativeness. Studies with funding from the National Institute of Mental Health (NIMH) were more likely than those without NIMH funding to document the inclusion of patients from minority groups (30 percent compared with 20 percent). Randomized studies were more likely than nonrandomized studies to document the inclusion of patients from minority groups (28 percent compared with 17 percent), include patients with comorbid psychiatric conditions (31 percent compared with 19 percent), and attend to sample representativeness (28 percent compared with 15 percent). Modest improvements were seen over time in inclusion of patients from minority groups, inclusion of patients with psychiatric comorbidities, and attention to sample representativeness. Conclusions: Generalizability of studies on treatments and outcomes, whether experimental or observational, remained low and poorly documented over the 16-year period.
引用
收藏
页码:1261 / 1268
页数:8
相关论文
共 23 条
[11]   Methodological and political issues in clinical pharmacology research by the year 2000 [J].
Carné, X ;
Arnaiz, JA .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 55 (11-12) :781-785
[12]  
COCHRANE AL, 1971, EFFECTIVENESS EFFICA
[13]   Problems in the "evidence" of "evidence-based medicine" [J].
Feinstein, AR ;
Horwitz, RI .
AMERICAN JOURNAL OF MEDICINE, 1997, 103 (06) :529-535
[14]  
FISHMAN DB, 2000, J PRAGMATIC CASE STU
[15]  
Herman J, 1998, J Eval Clin Pract, V4, P283
[16]   Systematic reviews in health care -: Assessing the quality of controlled clinical trials [J].
Jüni, P ;
Altman, DG ;
Egger, M .
BMJ-BRITISH MEDICAL JOURNAL, 2001, 323 (7303) :42-46
[17]   THE DESIGN OF REPLICATED STUDIES [J].
LINDSAY, RM ;
EHRENBERG, ASC .
AMERICAN STATISTICIAN, 1993, 47 (03) :217-228
[18]  
NORQUIST G, 1999, EXPANDING FRONTIER T
[19]  
Stewart A. L., 1992, MEASURING FUNCTIONIN
[20]   Practical clinical trials - Increasing the value of clinical research for decision making in clinical and health policy [J].
Tunis, SR ;
Stryer, DB ;
Clancy, CM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (12) :1624-1632